Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05660083
Title Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Methodist Hospital Research Institute
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.